Close Close
ThinkAdvisor
Two people mulling over an iPad

Life Health > Life Insurance > Permanent Life Insurance

Accelerated Underwriting and COVID-19: Life Insurance Lessons Learned

X
Your article was successfully shared with the contacts you provided.

What You Need to Know

  • Life insurance have been trying to simplify and speed up life underwriting.
  • COVID-19 has put new underwriting strategies through a brutal test.
  • One challenge has been gaps and lack of structure in alternative data sources.

The COVID-19 pandemic introduced new challenges and opportunities for life insurers.

Deaths from SARS-CoV-2 not only pressured benefit costs, but also increased consumer demand for life insurance products.

Meanwhile, conducting medical exams and blood tests — the mainstays for procuring underwriting information — became nearly impossible due to public policy decisions made in an effort to quell the spread of the novel coronavirus.

Life insurers needed to pivot — and fast.

Thanks to accelerated or “fluidless” underwriting, the industry learned it was more agile than previously realized.

Moving quickly and carefully, life insurers reconsidered previously underused data sources and already-established processes and systems to meet customer demand, discover new products, and ensure solvency in a sea of present and future unknowns.

Here are some lessons life insurers have learned.

1: Digital health data is useful for accelerated underwriting.

Digital health data can potentially be used in lieu of traditional labs and paramedical exams.

Incorporating alternative evidence from sources such as electronic health records (EHR), clinical labs, and medical claims data can help improve consumer experience and accelerate the underwriting process.

However, the data has limitations. Digital health records generally do not provide the same level of protective value as traditional labs.

In addition, they often lack uniformity and structure.

To bolster automation, this hurdle must be overcome.

2:  Accelerated underwriting requires an infrastructure that brings together data from disparate sources in an understandable way.

If the collection process is not set up appropriately, underwriters may face a deluge of information, making it difficult to identify relevant data.

Accelerated underwriting, which is designed to evolve, offers a framework for quickening the process of assessing mortality risk for writing policies by adjusting underwriting rules and models.

By setting up a data flow and system that pulls in the information from multiple sources and synthesizes it for underwriter review, alternative data is becoming much more valuable to the underwriting process.

3: Accelerated underwriting should be used only where it makes sense.

Determining the relevance of alternative data could depend on the applicant, life insurance product, insurer’s underwriting appetite and other factors.

The value of an alternative data source varies case by case.

For example, one applicant’s lab records may include a full blood panel, while another person’s may provide only a flu test.

4: Creating guidelines for risk assessment and pricing is necessary to move forward strategically.

Alternative underwriting programs are unique to each insurer, but enough commonalities exist to apply valuable evaluation tools for multiple applications.

Setting up a more rigorous framework for permanent change starts with observing in-market results to identify programs and program features worth maintaining.

Determining which alternative tools are the most protective and most usable while best serving the market can provide the basis for creating guidelines for risk assessment and pricing.

5: No matter how much underwriting is automated and fine-tuned with additional data and models, underwriters remain critically important.

Live human underwriters can evaluate information and see the big picture for more complex risks like no machine can.

In conclusion, there is nothing like a real-world test to realize an industry’s strengths and weaknesses.

The complications introduced by COVID-19 affirmed that the life insurance industry has the financial strength to withstand a major market disruption, the agility to adapt to an unexpected crisis, and the tools of innovation necessary to better serve its customers in the future.


Catie MuccigrossoCatie Muccigrosso is vice president and chief underwriter at Reinsurance Group of America, a life and health reinsurer.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.